Maria C. Freire
Independent DirectorDr. Maria C. Freire, Ph.D., serves as an Independent Director at Biogen Inc. since June 2, 2021 and serves as its Chairman since June 09, 2026. Dr. Freire is Founder and Principal of The Freire Group. Dr. Freire serves as a Director at Keystone Symposia On Molecular And Cellular Biology (Inc). Dr. Freire has served as an Independent Director of Alexandria Real Estate Equities, Inc. since April 2012. She is Director at Exelixis Inc. and Keystone Symposia on Molecular and Cell Biology. Dr. Freire was the President and Executive Director and Member of the Board of Directors of Foundation for the National Institutes of Health Inc. since 2012 until September 2021. Prior to her appointment at the FNIH, she was the President and as a member of the board of directors of the Albert and Mary Lasker Foundation from March 2008 to November 2012, where she established programmatic initiatives that expanded the brand and reach of the foundation. From 2001 to 2008, she served as President and Chief Executive Officer of the Global Alliance for TB Drug Development (TB Alliance) from 2001 to 2008, Director of the Office of Technology Transfer at the National Institutes of Health from 1995 to 2001 and from 1995 to 2001, she directed the Office of Technology Transfer at the NIH. She has been Director of Exelixis, Inc. since April 5, 2018. She served as Director of Koneksa Health Inc. since July 2022. In 2017 received Gold Stevie Award for “Woman of the Year,” the U.S. Department of Health and Human Services Secretary’s Award for Distinguished Service, the Arthur S. Fleming Award and the Bayh-Dole Award. She is widely recognized as an expert in technology commercialization and has a wide range of experience in the public and private biomedical sectors. Dr. Freire is active on national and international boards. Dr. Freire has significant knowledge and experience with respect to medical research, the pharmaceutical industry and government healthcare policymaking. She is a Member of the Science Board to the U.S. Food and Drug Administration (“FDA”), the World Health Organization Commission on Intellectual Property Rights, Innovation and Public Health and the United Nations Secretary General’s High Level Panel on Access to Medicines, which advises the FDA Commissioner; is the Chair of the Business Advisory Board of the Institute for Research in Biomedicine in Barcelona, Spain; has served as a Member of the Commission on a Global Health Risk Framework for the Future of the National Academy of Medicine and is a Member of the UN Secretary General’s High-Level Panel on Access to Medicines. She is the recipient of numerous awards, including the HHS Secretary’s Award for Distinguished Service, the Arthur S. Flemming Award and the Bayh-Dole Award. She is a Member of the National Academy of Medicine and the Council on Foreign Relations. Dr. Freire obtained her BS degree at the Universidad Peruana Cayetano Heredia in Lima, Peru and her PhD in Biophysics from the University of Virginia and completed postgraduate work in Immunology and Virology at the University of Virginia and the University of Tennessee, respectively and at the John F. Kennedy School of Government, Harvard University.
Positions
- Company NameExelixis, Inc.Stock CodeEXELPositionIndependent DirectorColleagues
- SPStelios PapadopoulosCo-Founder & Independent Chair of the Board
- MMMichael M. MorrisseyCEO, President & Director
- CJChristopher J. SennerExecutive VP & CFO
- BJBrenda J. HeftiSenior VP & General Counsel
- DTDana T. AftabExecutive Vice President of Research & Development
- JLJack L. WyszomierskiIndependent Director
- JAJulie Anne SmithIndependent Director
- MCMaria C. FreireIndependent Director
- Company NameAlexandria Real Estate Equities, Inc.Stock CodeAREPositionIndependent DirectorColleagues
- JSJoel S. MarcusFounder & Executive Chairman
- PMPeter M. MogliaCEO & Chief Investment Officer
- JHJohn Hart ColeCo-President & Co-Regional Market Director of Seattle
- HLHunter L. KassCo-President & Regional Market Director of Greater Boston
- MEMarc E. BindaCFO & Treasurer
- RHRichard Hunter KleinIndependent Director
- SRSteven Robert HashLead Independent Director
- JPJames P. CainIndependent Director
- Company NameBiogen Inc.Stock CodeBIIBPositionIndependent Chair of the BoardColleagues
- CAChristopher A. ViehbacherPresident, CEO & Director
- MCMaria C. FreireIndependent Chair of the Board
- RCRobin C. KramerExecutive VP & CFO
- NMNicole MurphyExecutive VP and Head of Pharmaceutical Operations & Technology
- PSPriya SinghalExecutive VP & Head of Development
- SGSean GodboutVP, Chief Accounting Officer & Global Corporate Controller
- JBJesus B. MantasIndependent Director
- MDMonish D. PatolawalaIndependent Director
- EKEric K. RowinskyIndependent Director
